• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新冠疫情对非洲白喉、破伤风、百日咳联合疫苗接种趋势的影响:一项Joinpoint回归分析。

COVID-19 Impact on DTP Vaccination Trends in Africa: A Joinpoint Regression Analysis.

作者信息

Aguinaga-Ontoso Ines, Guillen-Aguinaga Sara, Guillen-Aguinaga Laura, Alas-Brun Rosa, Onambele Luc, Aguinaga-Ontoso Enrique, Guillen-Grima Francisco

机构信息

Department of Health Sciences, Public University of Navarra, 31008 Pamplona, Spain.

Healthcare Research Institute of Navarra (IdiSNA), 31008 Pamplona, Spain.

出版信息

Vaccines (Basel). 2023 Jun 15;11(6):1103. doi: 10.3390/vaccines11061103.

DOI:10.3390/vaccines11061103
PMID:37376492
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10305165/
Abstract

BACKGROUND

Deaths due to vaccine-preventable diseases are one of the leading causes of death among African children. Vaccine coverage is an essential measure to decrease infant mortality. The COVID-19 pandemic has affected the healthcare system and may have disrupted vaccine coverage.

METHODS

DTP third doses (DTP3) Vaccine Coverage was extracted from UNICEF databases from 2012 to 2021 (the last available date). Joinpoint regression was performed to detect the point where the trend changed. The annual percentage change (APC) with 95% confidence intervals (95% CI) was calculated for Africa and the regions. We compared DTP3 vaccination coverage in 2019-2021 in each country using the Chi-square test.

RESULT

During the whole period, the vaccine coverage in Africa increased with an Annual Percent change of 1.2% (IC 95% 0.9-1.5): We detected one joinpoint in 2019. In 2019-2021, there was a decrease in DTP3 coverage with an APC of -3.5 (95% -6.0; -0,9). ( < 0.001). Vaccination rates decreased in many regions of Sub-Saharan Africa, especially in Eastern and Southern Africa. There were 26 countries (Angola, Cabo Verde, Comoros, Congo, Côte d'Ivoire, Democratic Republic of the Congo, Djibouti, Ethiopia, Eswatini, The Gambia, Guinea-Bissau, Liberia, Madagascar, Malawi, Mauritania, Mauritius, Mozambique, Rwanda, Senegal, Seychelles, Sierra Leone, Sudan, Tanzania, Togo, Tunisia, Uganda, and Zimbabwe) where the vaccine coverage during the two years decreased. There were 10 countries (Angola, Cabo Verde, Comoros, Democratic Republic of the Congo, Eswatini, The Gambia, Mozambique, Rwanda, Senegal, and Sudan) where the joinpoint regression detected a change in the trend.

CONCLUSIONS

COVID-19 has disrupted vaccine coverage, decreasing it all over Africa.

摘要

背景

疫苗可预防疾病导致的死亡是非洲儿童主要死因之一。疫苗接种覆盖率是降低婴儿死亡率的一项重要指标。新冠疫情已对医疗系统产生影响,可能扰乱了疫苗接种覆盖率。

方法

从联合国儿童基金会数据库中提取2012年至2021年(可获取的最新日期)的百白破第三剂(DTP3)疫苗接种覆盖率。进行连接点回归以检测趋势发生变化的点。计算非洲及各区域的年度百分比变化(APC)及其95%置信区间(95%CI)。我们使用卡方检验比较了2019 - 2021年每个国家的DTP3疫苗接种覆盖率。

结果

在整个期间,非洲的疫苗接种覆盖率以1.2%(IC 95% 0.9 - 1.5)的年度百分比变化上升:我们在2019年检测到一个连接点。在2019 - 2021年期间,DTP3覆盖率下降,APC为 - 3.5(95% - 6.0; - 0.9)(<0.001)。撒哈拉以南非洲的许多地区疫苗接种率下降,尤其是在东部和南部非洲。有26个国家(安哥拉、佛得角、科摩罗、刚果、科特迪瓦、刚果民主共和国、吉布提、埃塞俄比亚、斯威士兰、冈比亚、几内亚比绍、利比里亚、马达加斯加、马拉维、毛里塔尼亚、毛里求斯、莫桑比克、卢旺达、塞内加尔、塞舌尔、塞拉利昂、苏丹、坦桑尼亚、多哥、突尼斯、乌干达和津巴布韦)在这两年间疫苗接种覆盖率下降。有10个国家(安哥拉、佛得角、科摩罗、刚果民主共和国、斯威士兰、冈比亚、莫桑比克、卢旺达、塞内加尔和苏丹)连接点回归检测到趋势变化。

结论

新冠疫情扰乱了疫苗接种覆盖率,导致整个非洲的覆盖率下降。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/dce57a5b4ffe/vaccines-11-01103-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/7a2a307f34d6/vaccines-11-01103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/25149ae90cc5/vaccines-11-01103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/318641abd2d5/vaccines-11-01103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/4ecc581394cc/vaccines-11-01103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/6600bc8b645b/vaccines-11-01103-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/75c274d745b9/vaccines-11-01103-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/c89a6274b035/vaccines-11-01103-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/cc196d68d82f/vaccines-11-01103-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/3df4009f6f68/vaccines-11-01103-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/9f862fae6389/vaccines-11-01103-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/0fb3d4ba1c9b/vaccines-11-01103-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/25d93768f3bf/vaccines-11-01103-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/3e9e9c8a5fad/vaccines-11-01103-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/370a7bc98dbd/vaccines-11-01103-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/b4e9abdcd809/vaccines-11-01103-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/283276437f83/vaccines-11-01103-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/05c64f831344/vaccines-11-01103-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/4d6674d53712/vaccines-11-01103-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/dce57a5b4ffe/vaccines-11-01103-g019.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/7a2a307f34d6/vaccines-11-01103-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/25149ae90cc5/vaccines-11-01103-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/318641abd2d5/vaccines-11-01103-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/4ecc581394cc/vaccines-11-01103-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/6600bc8b645b/vaccines-11-01103-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/75c274d745b9/vaccines-11-01103-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/c89a6274b035/vaccines-11-01103-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/cc196d68d82f/vaccines-11-01103-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/3df4009f6f68/vaccines-11-01103-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/9f862fae6389/vaccines-11-01103-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/0fb3d4ba1c9b/vaccines-11-01103-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/25d93768f3bf/vaccines-11-01103-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/3e9e9c8a5fad/vaccines-11-01103-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/370a7bc98dbd/vaccines-11-01103-g014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/b4e9abdcd809/vaccines-11-01103-g015.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/283276437f83/vaccines-11-01103-g016.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/05c64f831344/vaccines-11-01103-g017.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/4d6674d53712/vaccines-11-01103-g018.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e669/10305165/dce57a5b4ffe/vaccines-11-01103-g019.jpg

相似文献

1
COVID-19 Impact on DTP Vaccination Trends in Africa: A Joinpoint Regression Analysis.新冠疫情对非洲白喉、破伤风、百日咳联合疫苗接种趋势的影响:一项Joinpoint回归分析。
Vaccines (Basel). 2023 Jun 15;11(6):1103. doi: 10.3390/vaccines11061103.
2
A SARS-CoV-2 Surveillance System in Sub-Saharan Africa: Modeling Study for Persistence and Transmission to Inform Policy.撒哈拉以南非洲的新冠病毒监测系统:关于持续存在和传播以指导政策的建模研究
J Med Internet Res. 2020 Nov 19;22(11):e24248. doi: 10.2196/24248.
3
Has COVID-19 Affected DTP3 Vaccination in the Americas?新冠疫情对美洲地区的百白破三联疫苗(DTP3)接种有影响吗?
Vaccines (Basel). 2024 Feb 25;12(3):238. doi: 10.3390/vaccines12030238.
4
Revisiting sub-Saharan African countries' drug problems: health, social, economic costs, and drug control policy.重新审视撒哈拉以南非洲国家的毒品问题:健康、社会、经济成本及毒品管制政策。
Subst Use Misuse. 2002 Feb;37(3):265-90. doi: 10.1081/ja-120002479.
5
Terrorist Attacks in Sub-Saharan Africa from 1970 through 2020: Analysis and Impact from a Counter-Terrorism Medicine Perspective.1970年至2020年撒哈拉以南非洲的恐怖袭击:反恐医学视角的分析与影响
Prehosp Disaster Med. 2023 Apr;38(2):216-222. doi: 10.1017/S1049023X23000080. Epub 2023 Jan 30.
6
A comparative review of governments' views on objectives and policy instruments in the field of population and development.各国政府对人口与发展领域目标及政策手段的观点比较综述。
Afr Popul Newsl. 1982 Jul-Dec(40-41):1-21.
7
Population needs identified for assistance in some ECA member states.一些欧洲和中亚地区(ECA)成员国确定了需要援助的人群。
Afr Popul Newsl. 1983 Jul-Dec(44-45):17-8.
8
Expanded programme on immunization (EPI). Immunization schedules in the WHO African region, 1995.扩大免疫规划(EPI)。1995年世界卫生组织非洲区域免疫接种时间表。
Wkly Epidemiol Rec. 1996 Mar 22;71(12):90-4.
9
COVID-19 vaccination implementation in 52 African countries: trajectory and implications for future pandemic preparedness.52 个非洲国家的 COVID-19 疫苗接种实施情况:轨迹和对未来大流行防范的影响。
BMJ Glob Health. 2023 Dec 6;8(12):e013073. doi: 10.1136/bmjgh-2023-013073.
10
Summary of country-level activities in population education in the African region: Unesco experience.非洲地区国家层面人口教育活动总结:联合国教科文组织的经验
Educafrica. 1985 Jun(12):199-207.

引用本文的文献

1
Trends in DTP3 Vaccination in Asia (2012-2023).亚洲地区三剂次白百破疫苗接种趋势(2012 - 2023年)
Vaccines (Basel). 2025 Aug 19;13(8):877. doi: 10.3390/vaccines13080877.
2
Global burden of occupational ergonomic factor-induced low back pain, 1990~2021: data analysis and projections of the global burden of disease.1990年至2021年职业工效学因素所致下背痛的全球负担:全球疾病负担的数据分析与预测
Front Public Health. 2025 May 27;13:1573828. doi: 10.3389/fpubh.2025.1573828. eCollection 2025.
3
Trend analysis of antidepressant consumption in Italy from 2008 to 2022 in a public health perspective.

本文引用的文献

1
Incomplete immunization and its determinants among children in Africa: Systematic review and meta-analysis.非洲儿童不完全免疫及其决定因素:系统评价和荟萃分析。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2202125. doi: 10.1080/21645515.2023.2202125. Epub 2023 May 5.
2
The Impact of a Revised National Childhood Immunization Schedule on Vaccination Defaulters.修订后的国家儿童免疫规划对疫苗接种未完成者的影响。
Vaccines (Basel). 2023 Apr 17;11(4):859. doi: 10.3390/vaccines11040859.
3
Low Vaccine Coverage and Factors Associated with Incomplete Childhood Immunization in Racial/Ethnic Minorities and Rural Groups, Central Brazil.
从公共卫生角度对2008年至2022年意大利抗抑郁药消费情况的趋势分析。
Sci Rep. 2025 Apr 9;15(1):12124. doi: 10.1038/s41598-025-96037-z.
4
The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012-2023).2019冠状病毒病对欧洲百白破三联疫苗(DTP3)接种覆盖率的影响(2012 - 2023年)
Vaccines (Basel). 2024 Dec 24;13(1):6. doi: 10.3390/vaccines13010006.
5
Trends of Diphtheria-Tetanus-Pertussis and Measles Vaccine Coverage Preceding and during the COVID-19 Pandemic: An Analysis of the WHO European Region from 2000 to 2022.2019冠状病毒病大流行之前及期间白喉-破伤风-百日咳和麻疹疫苗接种率的趋势:2000年至2022年世界卫生组织欧洲区域分析
Vaccines (Basel). 2024 Oct 6;12(10):1145. doi: 10.3390/vaccines12101145.
6
How did the introduction of the measles-containing vaccine second dose (MCV2) affect measles vaccine uptake? - evidence from Nigeria.含麻疹成分疫苗第二剂(MCV2)的引入如何影响麻疹疫苗接种率?——来自尼日利亚的证据。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2355036. doi: 10.1080/21645515.2024.2355036. Epub 2024 May 23.
7
Has COVID-19 Affected DTP3 Vaccination in the Americas?新冠疫情对美洲地区的百白破三联疫苗(DTP3)接种有影响吗?
Vaccines (Basel). 2024 Feb 25;12(3):238. doi: 10.3390/vaccines12030238.
8
Informal health sector and routine immunization: making the case for harnessing the potentials of patent medicine vendors for the big catch-up to reduce zero-dose children in sub-Saharan Africa.非正规卫生部门与常规免疫:以专利药品销售商为切入点,挖掘潜力,实现撒哈拉以南非洲地区儿童零剂量接种的大追赶。
Front Public Health. 2024 Mar 7;12:1353902. doi: 10.3389/fpubh.2024.1353902. eCollection 2024.
9
Access to DTP-Based Combination Vaccines in Asia-Pacific Countries between 2019 and 2022.2019年至2022年期间亚太国家获得基于白喉、破伤风和百日咳(DTP)的联合疫苗情况。
Vaccines (Basel). 2023 Dec 28;12(1):33. doi: 10.3390/vaccines12010033.
10
Correlates of COVID-19 Vaccine Acceptance and Hesitancy in Rural Communities in Western Kenya.肯尼亚西部农村社区对新冠疫苗的接受度与犹豫态度的相关因素
Vaccines (Basel). 2023 Sep 23;11(10):1516. doi: 10.3390/vaccines11101516.
巴西中部种族/民族少数群体和农村群体中疫苗接种覆盖率低及与儿童免疫接种不完整相关的因素
Vaccines (Basel). 2023 Apr 13;11(4):838. doi: 10.3390/vaccines11040838.
4
The Pan American Health Organization: 120 years in the Americas hemisphere.泛美卫生组织:在美洲地区的120年。
Lancet Reg Health Am. 2023 Apr 6;21:100488. doi: 10.1016/j.lana.2023.100488. eCollection 2023 May.
5
Socioeconomic and residence-based related inequality in childhood vaccination in Sub-Saharan Africa: Evidence from Benin.撒哈拉以南非洲地区儿童疫苗接种中基于社会经济和居住情况的相关不平等:来自贝宁的证据。
Health Sci Rep. 2023 Apr 20;6(4):e1198. doi: 10.1002/hsr2.1198. eCollection 2023 Apr.
6
Vaccination following the expanded programme on immunization schedule could help to reduce deaths in children under five hospitalized for pneumonia and severe pneumonia in a developing country.按照扩大免疫规划程序进行疫苗接种有助于降低发展中国家因肺炎和重症肺炎住院的五岁以下儿童的死亡率。
Front Pediatr. 2023 Mar 27;11:1054335. doi: 10.3389/fped.2023.1054335. eCollection 2023.
7
Vaccination Coverage and Risk Factors Associated With Incomplete Vaccination Among Children in Cambodia, Madagascar, and Senegal.柬埔寨、马达加斯加和塞内加尔儿童的疫苗接种覆盖率及与未完成疫苗接种相关的风险因素
Open Forum Infect Dis. 2023 Mar 10;10(4):ofad136. doi: 10.1093/ofid/ofad136. eCollection 2023 Apr.
8
The Hidden Impact of the COVID-19 Pandemic on Routine Childhood Immunization Coverage in Cameroon.新冠疫情对喀麦隆儿童常规免疫接种覆盖率的潜在影响
Vaccines (Basel). 2023 Mar 14;11(3):645. doi: 10.3390/vaccines11030645.
9
Closing the gap in childhood immunisation after the pandemic.弥合疫情后儿童免疫接种方面的差距。
BMJ. 2023 Mar 21;380:627. doi: 10.1136/bmj.p627.
10
Driving Paediatric Vaccine Recovery in Europe.推动欧洲儿科疫苗复苏。
Vaccines (Basel). 2023 Jan 15;11(1):184. doi: 10.3390/vaccines11010184.